Albatroz Therapeutics

📍 Singapore, Singapore🗓 Founded 2021👥 5 employees💰 Last funded 2023
Biotechnology🌐 albatroztherapeutics.com
Website LinkedIn
Albatroz Therapeutics is a pre-clinical stage biotech company developing therapeutic antibodies and ADCs to treat solid tumours and arthritis, based on its proprietary position over a novel target critical to ECM degradation.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2021
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Albatroz Therapeutics?
Albatroz Therapeutics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Albatroz Therapeutics last raise funding?
The most recent investment in Albatroz Therapeutics recorded on gritt.io was in 2023.
When was Albatroz Therapeutics founded?
Albatroz Therapeutics was founded in 2021.
What industry is Albatroz Therapeutics in?
Albatroz Therapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Albatroz Therapeutics based?
Albatroz Therapeutics is headquartered in Singapore, Singapore.